Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de deucravacitinib en participantes con lupus eritematoso sistémico activo (LES) (POETYK SLE-2).

Datos básicos

Código:
IM011-247
Protocolo:
IM011-247
EUDRACT:
2022-500700-22-00
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2023
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

BRISTOL MYERS SQUIBB INT. CORP

Resultados del Ensayo Clínico


18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry

Estrada-Alarcon, Paula V.; (...); Blanco, Ricardo

Meeting Abstract. 2023


ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis

De Miguel, Eugenio; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

  • Open Access.

After JAK Inhibitor Failure, "Switching" or "Cycling"?

Munoz Martinez, Pablo Francisco; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


AFTER JAK INHIBITOR FAILURE, 'SWITCHING' OR 'CYCLING'?

Munoz Martinez, P.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4124. 2023


Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis

Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

Autologous stem cell transplantation in systemic sclerosis: 4 cases.

de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres

Article. 10.1016/j.reumae.2025.501810. 2025


BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023


CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)

Torrat Noves, A. M.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023


COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)

Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023


COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL

Munoz Martinez, P.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023


Do antiTNF or Ustekinumab trough levels correlate with joint extraintestinal manifestations activity in Inflammatory bowel disease patients?

Madero Velazquez, L.; (...); Gutierrez Casbas, A.

Meeting Abstract. 2024

  • Open Access.

Do antiTNF through levels correlate with joint extraintestinal manifestations (EIM) activity in Inflammatory bowel disease (IBD) patients?

Madero Velazquez, L.; (...); Gutierrez Casbas, A.

Meeting Abstract. 2023


EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT

Altabas Gonzalez, I.; (...); Rua-Figueroa, I.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023


Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.

González-Jiménez P; (...); Méndez R

Article. 10.3390/biomedicines12102413. 2024

  • Open Access.

Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.

González-Jiménez P; (...); Menéndez R

Article. 10.3390/ijms241713194. 2023

  • Open Access.

Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.jneuroim.2024.578428. 2024


EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER

Mas Sanchez, L.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023


Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome

Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.

Riesco-Bárcena C; (...); Román-Ivorra J

Article. 10.1016/j.medcli.2024.07.020. 2024

  • Open Access.

Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab

Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients

Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024


Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)

De Miguel, Eugenio; (...); Blanco, Ricardo

Correction. 10.1136/rmdopen-2022-002507corr1. 2023

  • Open Access.

Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments

Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo

Meeting Abstract. 2023


JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.

Leal S; (...); Román-Ivorra JA

Letter. 10.55563/clinexprheumatol/4ao14k. 2024

  • Open Access.

Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry

Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo

Meeting Abstract. 2024

  • Open Access.

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara

Article. 10.1186/s13075-024-03468-6. 2025


Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime

Article. 10.1016/j.reuma.2024.03.005. 2024

  • Open Access.

Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome

Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19

González-Jiménez P; (...); Menéndez R

Article. 10.3390/ijms24076690. 2023

  • Open Access.

Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Zafra J; (...); Barragán I

Article. 10.3390/ijms25084533. 2024

  • Open Access.

Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.

Tortosa-Carreres J; (...); Pérez-Miralles FC

Article. 10.1016/j.msard.2024.105734. 2024


Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning

Román Ivorra JA; (...); Castellanos-Moreira R

Article. 10.1136/rmdopen-2023-003353. 2024

  • Open Access.

PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY

Alcantara Alvarez, I; (...); Roman Ivorra, J. A.

Meeting Abstract. 2024

  • Open Access.

PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE

Garcia, E. Grau; (...); Ivorra, J. A. Roman

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023


REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65

Grau Garcia, E.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023


Refractory RA Patients for Targeted Therapies in Real Life

Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres

Meeting Abstract. 2023


Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype

Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman

Article. 10.1016/j.medcli.2024.09.006. 2025


SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024

  • Open Access.

Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta

Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.

Meeting Abstract. 2024


Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.

Altabás-González I; (...); Rúa-Figueroa I

Article. 10.1093/rheumatology/kead696. 2024

  • Open Access.

USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES

Ortiz Sanjuan, F.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.2961. 2023


Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry

Molina-Collada, Juan; (...); Blanco, Ricardo

Meeting Abstract. 2023


Campos de estudio

Compartir